CN Stock MarketDetailed Quotes

600789 Shandong Lukang Pharmaceutical

Watchlist
  • 8.79
  • -0.33-3.62%
Market Closed Dec 13 15:00 CST
7.90BMarket Cap19.71P/E (TTM)

Shandong Lukang Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q9)Sep 30, 2024
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
Total operating revenue
-1.37%4.67B
2.93%3.28B
7.72%1.8B
9.34%6.15B
16.75%4.73B
18.66%3.19B
25.42%1.67B
14.17%5.62B
13.39%4.05B
11.80%2.69B
Operating revenue
-1.37%4.67B
2.93%3.28B
7.72%1.8B
9.34%6.15B
16.75%4.73B
18.66%3.19B
25.42%1.67B
14.17%5.62B
13.39%4.05B
11.80%2.69B
Other operating revenue
----
-32.42%34.94M
----
4.25%79.76M
----
29.29%51.7M
----
62.02%76.51M
----
35.62%39.99M
Total operating cost
-0.57%4.55B
3.55%3.18B
7.62%1.74B
8.29%5.91B
15.32%4.57B
17.35%3.07B
25.57%1.62B
13.81%5.46B
15.18%3.96B
14.20%2.61B
Operating cost
0.39%3.65B
1.95%2.54B
8.66%1.37B
5.88%4.63B
15.35%3.63B
18.40%2.49B
23.37%1.26B
16.76%4.37B
17.39%3.15B
16.54%2.11B
Operating tax surcharges
-1.31%38.63M
19.31%29.12M
29.01%15.44M
5.03%53.76M
11.64%39.14M
20.35%24.41M
11.31%11.97M
34.55%51.19M
34.20%35.06M
27.51%20.28M
Operating expense
-6.81%422.55M
7.85%307.82M
1.25%201.91M
21.58%577.59M
13.47%453.41M
19.71%285.4M
48.18%199.42M
-1.85%475.09M
7.84%399.58M
-0.39%238.42M
Administration expense
-1.94%167.74M
11.27%113.32M
13.88%55.45M
9.25%232.62M
26.82%171.05M
16.47%101.84M
12.05%48.69M
11.48%212.93M
3.43%134.88M
2.37%87.44M
Financial expense
1.92%45.24M
65.66%24.02M
-28.74%17.58M
-14.78%66.64M
-11.33%44.39M
-52.18%14.5M
42.66%24.68M
14.73%78.2M
-0.59%50.06M
-4.10%30.32M
-Interest expense (Financial expense)
3.64%57.16M
8.59%36.77M
-0.71%19.03M
-19.25%79.17M
-24.54%55.15M
-15.24%33.86M
33.92%19.17M
50.54%98.04M
43.69%73.09M
19.23%39.94M
-Interest Income (Financial expense)
-36.74%-8.85M
-28.80%-6.11M
-26.94%-2.24M
-24.39%-8.94M
-13.84%-6.47M
-26.02%-4.74M
4.61%-1.76M
-3.81%-7.19M
8.96%-5.69M
18.75%-3.77M
Research and development
-2.83%223.17M
8.12%158.89M
11.92%80.66M
30.98%345.79M
18.10%229.68M
12.39%146.96M
19.76%72.07M
-0.76%264M
7.55%194.48M
20.05%130.76M
Credit Impairment Loss
-150.98%-10.28M
-224.37%-13.96M
-193.20%-7.08M
138.10%7.8M
223.91%20.16M
205.37%11.22M
242.88%7.6M
17.14%-20.48M
26.78%-16.27M
52.08%-10.65M
Asset Impairment Loss
129.29%3.52M
80.94%-4.86M
116.71%1.79M
-30.39%-54.68M
-2.94%-12.01M
-571.27%-25.52M
-1,555.84%-10.74M
-35.54%-41.94M
-4.22%-11.67M
66.04%-3.8M
Adjustment items of total operating cost
----
--0.01
----
----
----
----
----
----
----
----
Other net revenue
310.49%251.49M
608.16%217.21M
3,935.21%20.21M
291.20%33.08M
396.03%61.27M
479.84%30.67M
-90.77%500.92K
-20.33%-17.3M
190.27%12.35M
128.34%5.29M
Fair value change income
216.67%46.74K
-348.00%-152.52K
-583.33%-71.34K
-233.33%-68.88K
220.00%14.76K
725.00%61.5K
-89.29%14.76K
-54.35%51.66K
-350.00%-12.3K
-113.79%-9.84K
Invest income
-55.86%-5.91M
-95.30%-3.88M
-95.30%-1.77M
-8.39%-7.13M
-83.09%-3.79M
-47.20%-1.99M
-17.11%-907.46K
-99.68%-6.58M
-31.43%-2.07M
-173.17%-1.35M
-Including: Investment income associates
-55.86%-5.91M
-95.30%-3.88M
-95.30%-1.77M
-8.43%-7.17M
-83.09%-3.79M
-47.20%-1.99M
-17.11%-907.46K
-100.63%-6.61M
-31.43%-2.07M
-173.17%-1.35M
Asset deal income
98,040.85%155.94M
167,209.48%155.94M
-31.65%63.71K
-90.04%282K
-94.24%158.89K
25,367.03%93.2K
143,004.91%93.2K
1,719.78%2.83M
3,633.38%2.76M
100.46%365.98
Other revenue
90.67%108.18M
79.74%84.12M
514.37%27.28M
77.99%86.88M
43.23%56.74M
121.82%46.8M
-63.09%4.44M
10.17%48.81M
85.28%39.61M
63.31%21.1M
Adjusted Items effecting operating profit
----
--0.01
----
----
----
----
----
----
----
----
Operating profit
68.43%372.54M
114.71%320.17M
46.27%80.58M
82.92%272.13M
119.90%221.18M
95.43%149.12M
8.98%55.09M
28.23%148.77M
-14.99%100.58M
-18.83%76.3M
Add:Non operating Income
27.94%962.91K
83.06%780.1K
152.04%347.56K
-57.56%1.21M
-43.20%752.61K
-57.46%426.13K
-4.55%137.9K
30.22%2.84M
-38.80%1.32M
-11.22%1M
Less:Non operating expense
1,143.45%1.18M
-66.91%30.64K
-75.35%11.64K
-76.05%363.63K
140.78%94.51K
127.77%92.6K
149.21%47.23K
-67.14%1.52M
-89.73%39.25K
409.18%40.65K
Total profit
67.84%372.33M
114.73%320.92M
46.64%80.92M
81.87%272.98M
117.77%221.84M
93.43%149.45M
8.88%55.18M
32.15%150.1M
-15.18%101.87M
-18.78%77.26M
Less:Income tax cost
-29.61%15.41M
3.51%14.2M
28.10%9.95M
131.91%16.19M
205.97%21.89M
116.92%13.72M
69.24%7.77M
-70.53%6.98M
-75.46%7.15M
-72.17%6.33M
Net profit
78.51%356.92M
125.98%306.71M
49.67%70.97M
79.43%256.79M
111.11%199.95M
91.34%135.73M
2.87%47.41M
59.21%143.11M
4.15%94.71M
-2.01%70.93M
Net profit from continuing operation
78.51%356.92M
125.98%306.71M
49.67%70.97M
79.43%256.79M
111.11%199.95M
91.34%135.73M
2.87%47.41M
59.21%143.11M
4.15%94.71M
-2.01%70.93M
Less:Minority Profit
33.35%9.86M
55.20%6.75M
111.98%3.66M
108.07%10.62M
137.61%7.39M
92.29%4.35M
54.67%1.73M
543.65%5.1M
22.37%3.11M
8.27%2.26M
Net profit of parent company owners
80.24%347.06M
128.32%299.96M
47.32%67.31M
78.37%246.17M
110.21%192.55M
91.31%131.38M
1.59%45.69M
54.90%138.01M
3.63%91.6M
-2.31%68.67M
Earning per share
Basic earning per share
77.27%0.39
120.00%0.33
60.00%0.08
75.00%0.28
120.00%0.22
87.50%0.15
0.00%0.05
60.00%0.16
0.00%0.1
0.00%0.08
Diluted earning per share
85.71%0.39
135.71%0.33
60.00%0.08
86.67%0.28
110.00%0.21
75.00%0.14
0.00%0.05
50.00%0.15
11.11%0.1
0.00%0.08
Other composite income
36.03%-2.43M
36.03%-2.43M
-28.29%-5.15M
-120.20%-3.8M
-120.20%-3.8M
12.52%-4.01M
-23.31%-1.73M
-23.31%-1.73M
Other composite income of parent company owners
36.03%-2.43M
36.03%-2.43M
----
-28.29%-5.15M
-120.20%-3.8M
-120.20%-3.8M
----
12.52%-4.01M
-23.31%-1.73M
-23.31%-1.73M
Total composite income
80.73%354.49M
130.64%304.28M
49.67%70.97M
80.90%251.64M
110.94%196.15M
90.62%131.93M
2.87%47.41M
63.07%139.1M
3.85%92.99M
-2.51%69.21M
Total composite income of parent company owners
82.58%344.63M
133.22%297.53M
47.32%67.31M
79.87%241.02M
110.02%188.75M
90.56%127.58M
1.59%45.69M
58.56%134M
3.31%89.87M
-2.84%66.95M
Total composite income of minority owners
33.35%9.86M
55.20%6.75M
111.98%3.66M
108.07%10.62M
137.61%7.39M
92.29%4.35M
54.67%1.73M
543.65%5.1M
22.37%3.11M
8.27%2.26M
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
Auditor
--
--
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
--
Shanghui Certified Public Accountants (Special General Partnership)
--
--
(Q9)Sep 30, 2024(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022
Total operating revenue -1.37%4.67B2.93%3.28B7.72%1.8B9.34%6.15B16.75%4.73B18.66%3.19B25.42%1.67B14.17%5.62B13.39%4.05B11.80%2.69B
Operating revenue -1.37%4.67B2.93%3.28B7.72%1.8B9.34%6.15B16.75%4.73B18.66%3.19B25.42%1.67B14.17%5.62B13.39%4.05B11.80%2.69B
Other operating revenue -----32.42%34.94M----4.25%79.76M----29.29%51.7M----62.02%76.51M----35.62%39.99M
Total operating cost -0.57%4.55B3.55%3.18B7.62%1.74B8.29%5.91B15.32%4.57B17.35%3.07B25.57%1.62B13.81%5.46B15.18%3.96B14.20%2.61B
Operating cost 0.39%3.65B1.95%2.54B8.66%1.37B5.88%4.63B15.35%3.63B18.40%2.49B23.37%1.26B16.76%4.37B17.39%3.15B16.54%2.11B
Operating tax surcharges -1.31%38.63M19.31%29.12M29.01%15.44M5.03%53.76M11.64%39.14M20.35%24.41M11.31%11.97M34.55%51.19M34.20%35.06M27.51%20.28M
Operating expense -6.81%422.55M7.85%307.82M1.25%201.91M21.58%577.59M13.47%453.41M19.71%285.4M48.18%199.42M-1.85%475.09M7.84%399.58M-0.39%238.42M
Administration expense -1.94%167.74M11.27%113.32M13.88%55.45M9.25%232.62M26.82%171.05M16.47%101.84M12.05%48.69M11.48%212.93M3.43%134.88M2.37%87.44M
Financial expense 1.92%45.24M65.66%24.02M-28.74%17.58M-14.78%66.64M-11.33%44.39M-52.18%14.5M42.66%24.68M14.73%78.2M-0.59%50.06M-4.10%30.32M
-Interest expense (Financial expense) 3.64%57.16M8.59%36.77M-0.71%19.03M-19.25%79.17M-24.54%55.15M-15.24%33.86M33.92%19.17M50.54%98.04M43.69%73.09M19.23%39.94M
-Interest Income (Financial expense) -36.74%-8.85M-28.80%-6.11M-26.94%-2.24M-24.39%-8.94M-13.84%-6.47M-26.02%-4.74M4.61%-1.76M-3.81%-7.19M8.96%-5.69M18.75%-3.77M
Research and development -2.83%223.17M8.12%158.89M11.92%80.66M30.98%345.79M18.10%229.68M12.39%146.96M19.76%72.07M-0.76%264M7.55%194.48M20.05%130.76M
Credit Impairment Loss -150.98%-10.28M-224.37%-13.96M-193.20%-7.08M138.10%7.8M223.91%20.16M205.37%11.22M242.88%7.6M17.14%-20.48M26.78%-16.27M52.08%-10.65M
Asset Impairment Loss 129.29%3.52M80.94%-4.86M116.71%1.79M-30.39%-54.68M-2.94%-12.01M-571.27%-25.52M-1,555.84%-10.74M-35.54%-41.94M-4.22%-11.67M66.04%-3.8M
Adjustment items of total operating cost ------0.01--------------------------------
Other net revenue 310.49%251.49M608.16%217.21M3,935.21%20.21M291.20%33.08M396.03%61.27M479.84%30.67M-90.77%500.92K-20.33%-17.3M190.27%12.35M128.34%5.29M
Fair value change income 216.67%46.74K-348.00%-152.52K-583.33%-71.34K-233.33%-68.88K220.00%14.76K725.00%61.5K-89.29%14.76K-54.35%51.66K-350.00%-12.3K-113.79%-9.84K
Invest income -55.86%-5.91M-95.30%-3.88M-95.30%-1.77M-8.39%-7.13M-83.09%-3.79M-47.20%-1.99M-17.11%-907.46K-99.68%-6.58M-31.43%-2.07M-173.17%-1.35M
-Including: Investment income associates -55.86%-5.91M-95.30%-3.88M-95.30%-1.77M-8.43%-7.17M-83.09%-3.79M-47.20%-1.99M-17.11%-907.46K-100.63%-6.61M-31.43%-2.07M-173.17%-1.35M
Asset deal income 98,040.85%155.94M167,209.48%155.94M-31.65%63.71K-90.04%282K-94.24%158.89K25,367.03%93.2K143,004.91%93.2K1,719.78%2.83M3,633.38%2.76M100.46%365.98
Other revenue 90.67%108.18M79.74%84.12M514.37%27.28M77.99%86.88M43.23%56.74M121.82%46.8M-63.09%4.44M10.17%48.81M85.28%39.61M63.31%21.1M
Adjusted Items effecting operating profit ------0.01--------------------------------
Operating profit 68.43%372.54M114.71%320.17M46.27%80.58M82.92%272.13M119.90%221.18M95.43%149.12M8.98%55.09M28.23%148.77M-14.99%100.58M-18.83%76.3M
Add:Non operating Income 27.94%962.91K83.06%780.1K152.04%347.56K-57.56%1.21M-43.20%752.61K-57.46%426.13K-4.55%137.9K30.22%2.84M-38.80%1.32M-11.22%1M
Less:Non operating expense 1,143.45%1.18M-66.91%30.64K-75.35%11.64K-76.05%363.63K140.78%94.51K127.77%92.6K149.21%47.23K-67.14%1.52M-89.73%39.25K409.18%40.65K
Total profit 67.84%372.33M114.73%320.92M46.64%80.92M81.87%272.98M117.77%221.84M93.43%149.45M8.88%55.18M32.15%150.1M-15.18%101.87M-18.78%77.26M
Less:Income tax cost -29.61%15.41M3.51%14.2M28.10%9.95M131.91%16.19M205.97%21.89M116.92%13.72M69.24%7.77M-70.53%6.98M-75.46%7.15M-72.17%6.33M
Net profit 78.51%356.92M125.98%306.71M49.67%70.97M79.43%256.79M111.11%199.95M91.34%135.73M2.87%47.41M59.21%143.11M4.15%94.71M-2.01%70.93M
Net profit from continuing operation 78.51%356.92M125.98%306.71M49.67%70.97M79.43%256.79M111.11%199.95M91.34%135.73M2.87%47.41M59.21%143.11M4.15%94.71M-2.01%70.93M
Less:Minority Profit 33.35%9.86M55.20%6.75M111.98%3.66M108.07%10.62M137.61%7.39M92.29%4.35M54.67%1.73M543.65%5.1M22.37%3.11M8.27%2.26M
Net profit of parent company owners 80.24%347.06M128.32%299.96M47.32%67.31M78.37%246.17M110.21%192.55M91.31%131.38M1.59%45.69M54.90%138.01M3.63%91.6M-2.31%68.67M
Earning per share
Basic earning per share 77.27%0.39120.00%0.3360.00%0.0875.00%0.28120.00%0.2287.50%0.150.00%0.0560.00%0.160.00%0.10.00%0.08
Diluted earning per share 85.71%0.39135.71%0.3360.00%0.0886.67%0.28110.00%0.2175.00%0.140.00%0.0550.00%0.1511.11%0.10.00%0.08
Other composite income 36.03%-2.43M36.03%-2.43M-28.29%-5.15M-120.20%-3.8M-120.20%-3.8M12.52%-4.01M-23.31%-1.73M-23.31%-1.73M
Other composite income of parent company owners 36.03%-2.43M36.03%-2.43M-----28.29%-5.15M-120.20%-3.8M-120.20%-3.8M----12.52%-4.01M-23.31%-1.73M-23.31%-1.73M
Total composite income 80.73%354.49M130.64%304.28M49.67%70.97M80.90%251.64M110.94%196.15M90.62%131.93M2.87%47.41M63.07%139.1M3.85%92.99M-2.51%69.21M
Total composite income of parent company owners 82.58%344.63M133.22%297.53M47.32%67.31M79.87%241.02M110.02%188.75M90.56%127.58M1.59%45.69M58.56%134M3.31%89.87M-2.84%66.95M
Total composite income of minority owners 33.35%9.86M55.20%6.75M111.98%3.66M108.07%10.62M137.61%7.39M92.29%4.35M54.67%1.73M543.65%5.1M22.37%3.11M8.27%2.26M
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ------Unqualified opinion------Unqualified opinion----
Auditor ------Shanghui Certified Public Accountants (Special General Partnership)------Shanghui Certified Public Accountants (Special General Partnership)----

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Heat List
CN
Overall
Symbol
Price
% Chg

No Data

Investment Theme Disinfectant
Disinfectant
Intraday-1.44%
Superfungus
Superfungus
Intraday-1.74%
State-owned Enterprise Reform
State-owned Enterprise Reform
Intraday-1.75%